Clinical Investigation to Evaluate the Effectiveness and Safety of ECG App

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 673 participants.

Also called NCT05482503

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; single masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 673 participants (enrolled count) (from the registry)
Sponsor
Huawei Device Co., Ltd (from the registry)
Registry
  • NCT NCT05482503
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05482503. Non-randomized; single masking; primary purpose diagnostic. Start 2021-04-02 (actual); primary completion 2021-09-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Investigation to Evaluate the Effectiveness and Safety of ECG App
Condition
Arrhythmias, Cardiac
Intervention (Device)
12-Lead ECG (electrocardiogram)(I-lead)
Lead sponsor
Huawei Device Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct05482503
Content hash
3e736117695dc6610abec7545cb3f1eaff867647a7a1c13633f12ba8e23599dd